Target Price | $4.08 |
Price | $1.32 |
Potential |
209.09%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Geron Corporation 2026 .
The average Geron Corporation target price is $4.08.
This is
209.09%
register free of charge
$6.30
377.27%
register free of charge
$1.52
14.77%
register free of charge
|
|
A rating was issued by 15 analysts: 11 Analysts recommend Geron Corporation to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Geron Corporation stock has an average upside potential 2026 of
209.09%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 76.99 | 201.29 |
31,979.17% | 161.45% | |
EBITDA Margin | -224.07% | -24.83% |
99.72% | 88.92% | |
Net Margin | -226.74% | -40.89% |
99.70% | 81.97% |
12 Analysts have issued a sales forecast Geron Corporation 2025 . The average Geron Corporation sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Geron Corporation EBITDA forecast 2025. The average Geron Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Geron Corporation Analysts have issued a net profit forecast 2025. The average Geron Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.27 | -0.13 |
15.63% | 51.85% | |
P/E | negative | |
EV/Sales | 2.79 |
12 Analysts have issued a Geron Corporation forecast for earnings per share. The average Geron Corporation EPS is
This results in the following potential growth metrics and future valuations:
Geron Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Goldman Sachs |
Locked
➜
Locked
|
Locked | Jul 10 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | May 08 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
Needham |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Analyst Rating | Date |
---|---|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Jul 10 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
May 08 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
Needham:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.